Axsome Therapeutics Recognizes Mental Health Month

mental-health

Axsome Therapeutics announced its support for Mental Health Month 2026 alongside the broader mental health advocacy community. The company is sharing resources to support individuals affected by mental health conditions, their families, and surrounding communities in recognition of this year’s “More Good Days Together” theme.

Mental health conditions are highly prevalent in the U.S., with nearly 1 in 4 adults living with a mental illness. Major depressive disorder (MDD), one of the most common mental health conditions, is a leading cause of disability worldwide and impacts over 21 million adults in the U.S. alone. Nearly 90% of people living with depression report difficulty with work, home, or social activities due to their symptoms, underscoring the impact depression can have on daily life.

Axsome’s mission is to develop and deliver transformative medicines to improve brain health of individuals affected by central nervous system conditions, including those living with difficult-to-treat mental illness. The company highlighted non-profit organizations and resources that provide education, tools, and community support, including the 2026 Mental Health Month Action Guide and the Anxiety and Depression Association of America’s “Find Your Therapist” platform, which helps connect people with licensed mental health professionals who specialize in treating anxiety, depression, OCD, PTSD, and related disorders.

The National Alliance on Mental Illness (NAMI) provides lived-experience and evidence-based support for families and individuals affected by mental illness. If someone is in crisis, the 988 Suicide & Crisis Lifeline is available 24 hours a day, 7 days a week, free and confidential. Trained counselors will listen, understand how problems are affecting the person, provide support, and connect them to resources if necessary.


This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://www.benzinga.com/pressreleases/26/05/g52359194/axsome-therapeutics-recognizes-mental-health-month